The most important first step in the Division of Antiviral Products (DAVP) Pre-IND process is to contact the DAVP Project Management Staff for a preliminary discussion regarding your product and development plans. If you are exploring product development for the treatment of a viral disease, Nina Mani, PhD, MPH can be contacted by telephone at (301) 796-1500 or by e-mail at nina.mani@fda.hhs.gov. You may also contact Karen Winestock by telephone at (301) 796-1500 or by email at karen.winestock@fda.hhs.gov.
